Jun 2, 2026 07:02AM
Apr 20, 2026 07:01AM
Apr 1, 2026 07:03AM
Jan 13, 2026 07:03AM
Dec 8, 2025 06:22AM
Nov 25, 2025 07:00AM
Jun 2, 2025 08:06AM Pasithea Therapeutics (KTTA) Presents Updated Interim Data from Ongoing Phase 1 Study of PAS-004
May 20, 2025 07:07AM
May 6, 2025 07:03AM
Apr 10, 2025 07:02AM
Feb 5, 2025 06:59AM
Nov 20, 2024 07:03AM
Sep 27, 2024 06:02AM
Sep 26, 2024 07:02AM Pasithea Therapeutics (KTTA) Reports Positive Initial Safety, Tolerability, Pharmacokinetic (PK), and Preliminary Efficacy Data from Phase 1 Trial of PAS-004
Sep 9, 2024 08:01AM

432,043 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All